Med. Weter. 71 (5), 281-285, 2015

full text

Cybulski W., Pasik K., Krasucka D., Łysiak E., Mitura A., Klimowicz A., Tomczyk G., Pietroń W.
Poultry vaccines available on the Polish market after the harmonization of the pharmaceutical code according to EU legislation: an analysis of trends at the domestic versus global scale
Poland’s accession to the European Union (EU) has entailed the implementation of mutual recognition procedures for the authorization of immunological veterinary medicinal products (IVMPs) since 2009. The aim of the study was to analyse data on the assortment and number of doses in the batches of vaccines for poultry authorized on the Polish market in 2010. These data, compared with the total output of doses in the same batches of IVMPs manufactured worldwide, revealed trends in the application of poultry vaccines in Poland. The results of the survey indicate that poultry IVMPs were the most important immunologicals on the Polish market in terms of variety and the numbers of doses. The dominant position of poultry IVMPs against viral diseases on the Polish market reflected the global trend. They accounted for 97.98% of all poultry IVMPs, followed by anti-bacterial (1.55%) and anti-parasitic IVMPs (0.47%). The order of the five most popular poultry IVMPs was the same on the Polish market as in the global markets, namely vaccines against IB, IBD, ND, MD and TRT. In contrast, anti-bacterial vaccines against Salmonellosis (SE and ST) took the 8th place in terms of their share of the total number of doses manufactured and sold on the Polish market, whereas the total number of doses manufactured globally situated them at the 15th place. Moreover, the position of some anti-viral vaccines was substantially different in Poland; namely relatively high dose counts in vaccines against MD, TRT, DD and SHS, as opposed to rather low shares of vaccine doses against AE, AP, ILT from what these were on the global market. In conclusion, these differences require thorough analysis and the recognition of trends in supply and demand terms accordingly sustainable vaccination programming. The findings might reveal a gap between immunoprophylaxis guidelines and current immunoprophylaxis needs relevant to epidemiological status of poultry flocks in Poland.
Key words: poultry vaccines, immunological veterinary medicinal products, veterinary pharmaceutical market, vaccine authorization